IRCCS MultiMedica, Value-based healthcare unit, Sesto San Giovanni (Milan), Italy.
School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy; Department of Emergency and Intensive Care, San Gerardo Hospital, Monza, Italy.
Chest. 2020 Nov;158(5):1967-1982. doi: 10.1016/j.chest.2020.05.605. Epub 2020 Jun 24.
Considerable variability exists regarding CO management in early ARDS, with the impact of arterial CO tension on management and outcomes poorly understood.
To determine the prevalence and impact of hypocapnia and hypercapnia on the management and outcomes of patients with early ARDS enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study, an international multicenter observational study.
Our primary objective was to examine the prevalence of day 1 and sustained (day 1 and 2) hypocapnia (Paco < 35 mm Hg), normocapnia (Paco 35-45 mm Hg), and hypercapnia (Paco > 45 mm Hg) in patients with ARDS. Secondary objectives included elucidating the effect of CO tension on ventilatory management and examining the relationship with ARDS outcome.
Of 2,813 patients analyzed, 551 (19.6%; 95%CI, 18.1-21.1) were hypocapnic, 1,018 (36.2%; 95% CI, 34.4-38.0) were normocapnic, and 1,214 (43.2%; 95% CI, 41.3-45.0) were hypercapnic, on day 1. Sustained hypocapnia was seen in 252 (9.3%; 95% CI, 8.2-10.4), sustained normocapnia in 544 (19.3%; 95% CI, 17.9-20.8), and sustained hypercapnia in 654 (24.1%; 95% CI, 22.5-25.7) patients. Hypocapnia was more frequent and severe in patients receiving noninvasive ventilation but also was observed in patients on controlled mechanical ventilation. Sustained hypocapnia was more frequent in middle-income countries, whereas sustained hypercapnia was more frequent in Europe. ARDS severity profile was highest in sustained hypercapnia, and these patients received more protective ventilation. No independent association was seen between arterial CO and outcome. In propensity-matched analyses, the hospital mortality rate was 36% in both sustained normocapnic and hypercapnic patients (P = 1.0). ICU mortality was higher in patients with mild to moderate ARDS receiving sustained hypocapnia (38.1%) compared with normocapnia (27.1%).
No evidence was found for benefit or harm with hypercapnia. Of concern, ICU mortality was higher with sustained hypocapnia in mild to moderate ARDS.
在早期急性呼吸窘迫综合征(ARDS)中,CO 管理存在相当大的差异,动脉 CO 张力对管理和结果的影响知之甚少。
为了确定低碳酸血症和高碳酸血症在接受 Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) 研究(一项国际多中心观察性研究)的早期 ARDS 患者管理和结局中的普遍性及其影响,该研究评估了动脉 CO 张力对通气管理的影响,并研究了与 ARDS 结局的关系。
我们的主要目的是检查 ARDS 患者第 1 天和持续(第 1 天和第 2 天)低碳酸血症(Paco <35mmHg)、正常碳酸血症(Paco 35-45mmHg)和高碳酸血症(Paco >45mmHg)的发生率。次要目标包括阐明 CO 张力对通气管理的影响,并研究其与 ARDS 结局的关系。
在分析的 2813 名患者中,551 名(19.6%;95%CI,18.1-21.1)为低碳酸血症,1018 名(36.2%;95%CI,34.4-38.0)为正常碳酸血症,1214 名(43.2%;95%CI,41.3-45.0)为高碳酸血症,第 1 天。252 名(9.3%;95%CI,8.2-10.4)患者持续低碳酸血症,544 名(19.3%;95%CI,17.9-20.8)患者持续正常碳酸血症,654 名(24.1%;95%CI,22.5-25.7)患者持续高碳酸血症。接受无创通气的患者低碳酸血症更频繁且更严重,但也观察到接受有创机械通气的患者存在低碳酸血症。持续低碳酸血症在中低收入国家更为常见,而持续高碳酸血症在欧洲更为常见。持续高碳酸血症患者 ARDS 严重程度最高,这些患者接受了更具保护性的通气。动脉 CO 与结局之间未见独立关联。在倾向评分匹配分析中,持续正常碳酸血症和高碳酸血症患者的 ICU 死亡率均为 36%(P=1.0)。与正常碳酸血症(27.1%)相比,轻度至中度 ARDS 患者持续低碳酸血症时 ICU 死亡率更高(38.1%)。
没有证据表明高碳酸血症有益或有害。需要注意的是,轻度至中度 ARDS 患者持续低碳酸血症时 ICU 死亡率更高。